Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7638)
All Articles published online
|
Nov 28, 2011 (publication date) through May 17, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sun C, Rosendahl AH, Ansari D, Andersson R. Proteome-based biomarkers in pancreatic cancer. World J Gastroenterol 2011; 17(44): 4845-4852 [PMID: 22171124 DOI: 10.3748/wjg.v17.i44.4845] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i44/4845.htm |
| Number | Citing Articles |
| 1 |
Meritxell Balmaña, Adrià Duran, Catarina Gomes, Esther Llop, Raquel López-Martos, M. Rosa Ortiz, Sílvia Barrabés, Celso A. Reis, Rosa Peracaula. Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues. International Journal of Biological Macromolecules 2018; 112: 33 doi: 10.1016/j.ijbiomac.2018.01.148
|
| 2 |
Sheng Pan, Teresa A. Brentnall, Ru Chen. Proteome alterations in pancreatic ductal adenocarcinoma. Cancer Letters 2020; 469: 429 doi: 10.1016/j.canlet.2019.11.020
|
| 3 |
Ulf Landegren, Maria Hammond. Cancer diagnostics based on plasma protein biomarkers: hard times but great expectations. Molecular Oncology 2021; 15(6): 1715 doi: 10.1002/1878-0261.12809
|
| 4 |
Yuanwei Xu, Yuefan Wang, Naseruddin Höti, David J. Clark, Shao‐Yung Chen, Hui Zhang. The next “sweet” spot for pancreatic ductal adenocarcinoma: Glycoprotein for early detection. Mass Spectrometry Reviews 2023; 42(2): 822 doi: 10.1002/mas.21748
|
| 5 |
Steven Haenen, Elke Clynen, Benoit Nemery, Peter H.M. Hoet, Jeroen A.J. Vanoirbeek. Biomarker discovery in asthma and COPD: Application of proteomics techniques in human and mice. EuPA Open Proteomics 2014; 4: 101 doi: 10.1016/j.euprot.2014.04.008
|
| 6 |
Hui-Lin Ye, Dou-Dou Li, Qing Lin, Yu Zhou, Quan-Bo Zhou, Bing Zeng, Zhi-Qiang Fu, Wen-Chao Gao, Yi-Min Liu, Rui-Wan Chen, Zhi-Hua Li, Ru-Fu Chen. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival. World Journal of Gastroenterology 2015; 21(21): 6621-6630 doi: 10.3748/wjg.v21.i21.6621
|
| 7 |
Paola Monterroso Diaz, Ashton Leehans, Prashanth Ravishankar, Anna Daily. Multiomic Approaches for Cancer Biomarker Discovery in Liquid Biopsies: Advances and Challenges. Biomarker Insights 2023; 18 doi: 10.1177/11772719231204508
|
| 8 |
Umashankar K. Ballehaninna, Ronald S. Chamberlain. Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9. Tumor Biology 2013; 34(6): 3279 doi: 10.1007/s13277-013-1033-3
|
| 9 |
Claire Jenkinson, Julie Earl, Paula Ghaneh, Christopher Halloran, Alfredo Carrato, William Greenhalf, John Neoptolemos, Eithne Costello. Biomarkers for early diagnosis of pancreatic cancer. Expert Review of Gastroenterology & Hepatology 2015; 9(3): 305 doi: 10.1586/17474124.2015.965145
|
| 10 |
一 张. Advances in Circulating Biomarkers of Pancreatic Cancer. Advances in Clinical Medicine 2021; 11(05): 2055 doi: 10.12677/ACM.2021.115294
|
| 11 |
Ruchika Bhawal, Ann L. Oberg, Sheng Zhang, Manish Kohli. Challenges and Opportunities in Clinical Applications of Blood-Based Proteomics in Cancer. Cancers 2020; 12(9): 2428 doi: 10.3390/cancers12092428
|
| 12 |
Tafadzwa Chihanga, Shenyuan Xu, Hannah N. Fultz, Jenna D. Nicholson, Mark D. Brombacher, Kayla Hawkins, Dan R. Fay, Maria M. Steil, Shuisong Ni, Michael A. Kennedy. How Early Can Pancreatic Tumors Be Detected Using NMR-Based Urine Metabolic Profiling? Identification of Early-Stage Biomarkers of Tumor Initiation and Progression in an Orthotopic Xenograft Mouse Model of Pancreatic Cancer. Metabolites 2025; 15(3): 142 doi: 10.3390/metabo15030142
|
| 13 |
Christina Loosse, Katrin Marcus, Bodo Schoenebeck. The Cytoskeleton. Neuromethods 2013; 79: 85 doi: 10.1007/978-1-62703-266-7_5
|
| 14 |
Célia Cintas, Thibaut Douché, Nicole Therville, Silvia Arcucci, Fernanda Ramos-Delgado, Céline Basset, Benoît Thibault, Julie Guillermet-Guibert. Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics. Cancers 2018; 10(6): 174 doi: 10.3390/cancers10060174
|
| 15 |
John A. Williams. Proteomics as a Systems Approach to Pancreatitis. Pancreas 2013; 42(6): 905 doi: 10.1097/MPA.0b013e31828fddc3
|
| 16 |
R Roy, D Zurakowski, J Wischhusen, C Frauenhoffer, S Hooshmand, M Kulke, M A Moses. Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies. British Journal of Cancer 2014; 111(9): 1772 doi: 10.1038/bjc.2014.462
|
| 17 |
Sheng Pan, Teresa A. Brentnall, Kimberly Kelly, Ru Chen. Tissue proteomics in pancreatic cancer study: Discovery, emerging technologies, and challenges. PROTEOMICS 2013; 13(3-4): 710 doi: 10.1002/pmic.201200319
|
| 18 |
Kaisheng Liu, Minshan Lai, Shaoxiang Wang, Kai Zheng, Shouxia Xie, Xiao Wang, Hesham H. Ali. Construction of a CXC Chemokine‐Based Prediction Model for the Prognosis of Colon Cancer. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/6107865
|
| 19 |
Sheng Pan, Teresa A. Brentnall, Ru Chen. Proteomics analysis of bodily fluids in pancreatic cancer. PROTEOMICS 2015; 15(15): 2705 doi: 10.1002/pmic.201400476
|
| 20 |
Nalin C. W. Goonesekere, Xiaosheng Wang, Lindsey Ludwig, Chittibabu Guda, Jörg D. Hoheisel. A Meta Analysis of Pancreatic Microarray Datasets Yields New Targets as Cancer Genes and Biomarkers. PLoS ONE 2014; 9(4): e93046 doi: 10.1371/journal.pone.0093046
|
| 21 |
Tania Angeles-Floriano, Guadalupe Rivera-Torruco, Paulina García-Maldonado, Esmeralda Juárez, Yolanda Gonzalez, Israel Parra-Ortega, Armando Vilchis-Ordoñez, Briceida Lopez-Martinez, Lourdes Arriaga-Pizano, Dario Orozco-Ruíz, José Refugio Torres-Nava, Paula Licona-Limón, Francisco López-Sosa, Alhelí Bremer, Lourdes Alvarez-Arellano, Ricardo Valle-Rios. Cell surface expression of GRP78 and CXCR4 is associated with childhood high-risk acute lymphoblastic leukemia at diagnostics. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-05857-w
|
| 22 |
Ying-Hui Teh, Xuan-Yi Sim, Sohaib Jumaah Owaid, Mohd Nazri Ismail, Lay-Harn Gam. Changes of Pancreatic Protein Profile Upon High Fat Diet Intake In Diabetic Rat Model. Malaysian Applied Biology 2024; 53(6): 49 doi: 10.55230/mabjournal.v53i6.4
|
| 23 |
Sheng Pan, Teresa A Brentnall, Ru Chen. Glycoproteins and glycoproteomics in pancreatic cancer. World Journal of Gastroenterology 2016; 22(42): 9288-9299 doi: 10.3748/wjg.v22.i42.9288
|
| 24 |
Dingyuan Hu, Daniel Ansari, Krzysztof Pawłowski, Qimin Zhou, Agata Sasor, Charlotte Welinder, Theresa Kristl, Monika Bauden, Melinda Rezeli, Yi Jiang, György Marko-Varga, Roland Andersson. Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma. Oncotarget 2018; 9(11): 9789 doi: 10.18632/oncotarget.23929
|
| 25 |
Danian Tong, Yujia Zhou, Wei Chen, Yang Deng, Lei Li, Zhenyi Jia, Dachuan Qi. T cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and susceptibility to pancreatic cancer. Molecular Biology Reports 2012; 39(11): 9941 doi: 10.1007/s11033-012-1862-y
|
| 26 |
Takeo Kawahara, Naoe Hotta, Yukiko Ozawa, Seiichi Kato, Keiko Kano, Yukihiro Yokoyama, Masato Nagino, Takashi Takahashi, Kiyoshi Yanagisawa, Martin Fernandez-Zapico. Quantitative Proteomic Profiling Identifies DPYSL3 as Pancreatic Ductal Adenocarcinoma-Associated Molecule That Regulates Cell Adhesion and Migration by Stabilization of Focal Adhesion Complex. PLoS ONE 2013; 8(12): e79654 doi: 10.1371/journal.pone.0079654
|
| 27 |
Ai-hua Zhang, Hui Sun, Guang-li Yan, Ying Han, Xi-jun Wang. Serum Proteomics in Biomedical Research: A Systematic Review. Applied Biochemistry and Biotechnology 2013; 170(4): 774 doi: 10.1007/s12010-013-0238-7
|
| 28 |
Katelyn F. Flick, Michele T. Yip-Schneider, Christopher M. Sublette, Rachel E. Simpson, Cameron L. Colgate, Huangbing Wu, Mazhar Soufi, John M. Dewitt, Amber L. Mosley, Eugene P. Ceppa, Jianjun Zhang, C. Max Schmidt. A Quantitative Global Proteomics Approach Identifies Candidate Urinary Biomarkers That Correlate With Intraductal Papillary Mucinous Neoplasm Dysplasia. Pancreas 2020; 49(8): 1044 doi: 10.1097/MPA.0000000000001628
|
| 29 |
Lucie Habartová, Bohuš Bunganič, Michal Tatarkovič, Miroslav Zavoral, Jana Vondroušová, Kamila Syslová, Vladimír Setnička. Chiroptical spectroscopy and metabolomics for blood‐based sensing of pancreatic cancer. Chirality 2018; 30(5): 581 doi: 10.1002/chir.22834
|
| 30 |
Cristina Jimenez-Luna, Carolina Torres, Raul Ortiz, Carmelo Dieguez, Joaquina Martinez-Galan, Consolacion Melguizo, Jose C. Prados, Octavio Caba. Proteomic biomarkers in body fluids associated with pancreatic cancer. Oncotarget 2018; 9(23): 16573 doi: 10.18632/oncotarget.24654
|
| 31 |
Krissi Danielsson, Daniel Ansari, Roland Andersson. Personalizing Pancreatic Cancer Medicine: What are the Challenges?. Personalized Medicine 2013; 10(1): 45 doi: 10.2217/pme.12.111
|